Wells Fargo & Company ARRIVENT BIOPHARMA INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
11,903
Previous 14,819 19.68%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-2,916 Reduced 19.68%
11,903 $0
Q1 2025

May 13, 2025
BUY
N/A
326 Added 2.25%
14,819 $0
Q4 2024

Feb 12, 2025
BUY
N/A
4,139 Added 39.97%
14,493 $0
Q3 2024

Nov 13, 2024
BUY
N/A
6,751 Added 187.37%
10,354 $0
Q2 2024

Aug 13, 2024
BUY
N/A
372 Added 11.51%
3,603 $0
Q1 2024

May 10, 2024
BUY
N/A
3,231 New
3,231 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email